New billing codes announced for emergency use, expanded access treatments
![CMS_update](/sites/default/files/styles/900x400/public/2018-04/CMS_update.jpg?itok=VTgL0hn3)
Effective Feb. 1, physicians and other health care providers and suppliers should use new National Uniform Billing Committee condition codes on claims for COVID-19 and other treatments authorized by the Food and Drug Administration for emergency use or expanded access, the Centers for Medicare & Medicaid Services announced.
The new condition codes are 91 for EUA services and 90 for services with expanded access approval.
Related News Articles
Headline
The Food and Drug Administration Aug. 22 granted emergency use authorization for two new combined COVID-19 and influenza tests. The Nano-Check Influenza-COVID-…
Headline
The Centers for Disease Control and Prevention's COVID-19 data tracker shows an 18.1% test positivity rate for the week ending Aug. 10, the highest it has been…
Headline
The Centers for Disease Control and Prevention Aug. 13 issued an advisory alerting of an uptick of cases of parvovirus B19 across the U.S. Parvovirus B19 is a…
Headline
Adults age 65 and older are encouraged to receive an updated dosage of the COVID-19 vaccine, the Centers for Disease Control and Prevention announced April 25…
Headline
Paxlovid may no longer be distributed with an emergency use label after March 8, the Food and Drug Administration announced. Providers may dispense unexpired…
Headline
The Food and Drug Administration’s independent Nonprescription Drugs Advisory Committee Sept. 12 by unanimous vote declared oral phenylephrine…